← Evidence map

ArticleNature reviews. Cardiology2023

Ruxolitinib is a CaMKII inhibitor that can be repurposed to prevent arrhythmias.

Karina HuynhPubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37400626